Ambulatory Blood Pressure Monitoring–Derived Short‐Term Blood Pressure Variability in Primary Aldosteronism
暂无分享,去创建一个
F. Veglio | B. Fabris | R. Carretta | M. Bardelli | A. Grillo | S. Bernardi | A. Rebellato | J. Burrello | F. Rabbia | F. Fallo
[1] J. Zicha,et al. Obesity-related hypertension: possible pathophysiological mechanisms. , 2014, The Journal of endocrinology.
[2] G. Parati,et al. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension , 2014, Hypertension Research.
[3] N. Sonino,et al. Ambulatory blood pressure monitoring-derived short-term blood pressure variability is increased in Cushing’s syndrome , 2014, Endocrine.
[4] G. Parati,et al. Prognostic Value of Blood Pressure Variability and Average Blood Pressure Levels in Patients With Hypertension and Diabetes , 2013, Diabetes Care.
[5] T. Zelinka,et al. Vascular Disturbances in Primary Aldosteronism: Clinical Evidence , 2012, Kidney and Blood Pressure Research.
[6] G. Mancia. Short- and long-term blood pressure variability: present and future. , 2012, Hypertension.
[7] C. Pilon,et al. Primary Aldosteronism and Metabolic Syndrome , 2011, Hormone and Metabolic Research.
[8] G. Fava,et al. Psychological assessment of primary aldosteronism: a controlled study. , 2011, The Journal of clinical endocrinology and metabolism.
[9] Alessandro Squizzato1 , 2,et al. The Influence of Pituitary, Adrenal, and Parathyroid Hormones on Hemostasis and Thrombosis , 2011, Seminars in thrombosis and hemostasis.
[10] P. Fesler,et al. Dietary Sodium, Aldosterone, and Left Ventricular Mass Changes During Long-Term Inhibition of the Renin-Angiotensin System , 2010, Hypertension.
[11] S. Nesbitt,et al. Reversible sympathetic overactivity in hypertensive patients with primary aldosteronism. , 2010, The Journal of clinical endocrinology and metabolism.
[12] E. O’Brien,et al. Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke , 2010, The Lancet Neurology.
[13] M. Stowasser,et al. Impact of Different Diagnostic Criteria During Adrenal Vein Sampling on Reproducibility of Subtype Diagnosis in Patients With Primary Aldosteronism , 2010, Hypertension.
[14] Marta Di Nicola,et al. Prognostic value of different indices of blood pressure variability in hypertensive patients. , 2009, American journal of hypertension.
[15] Y. Toya,et al. Identification of an Increased Short-Term Blood Pressure Variability on Ambulatory Blood Pressure Monitoring as a Coronary Risk Factor in Diabetic Hypertensives , 2009, Clinical and experimental hypertension.
[16] W. Young,et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. , 2008, The Journal of clinical endocrinology and metabolism.
[17] L. Sechi,et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment. , 2008, Archives of internal medicine.
[18] G. Parati,et al. A new method for assessing 24-h blood pressure variability after excluding the contribution of nocturnal blood pressure fall , 2007, Journal of hypertension.
[19] S. Liatis,et al. Sympathetic System Activity in Obesity and Metabolic Syndrome , 2006, Annals of the New York Academy of Sciences.
[20] G. Regolisti,et al. Comparison of confirmatory tests for the diagnosis of primary aldosteronism. , 2006, The Journal of clinical endocrinology and metabolism.
[21] M. Ermani,et al. Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. , 2006, The Journal of clinical endocrinology and metabolism.
[22] P. Milliez,et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. , 2005, Journal of the American College of Cardiology.
[23] Salvador A. Pintos,et al. A reliable index for the prognostic significance of blood pressure variability , 2005, Journal of hypertension.
[24] T. Thrasher,et al. Baroreceptors and the long‐term control of blood pressure , 2004, Experimental physiology.
[25] F. Veglio,et al. Drug Effects on Aldosterone/Plasma Renin Activity Ratio in Primary Aldosteronism , 2002, Hypertension.
[26] M. Kikuya,et al. Prognostic Significance of Blood Pressure and Heart Rate Variabilities: The Ohasama Study , 2000, Hypertension.
[27] M. Boscaro,et al. Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene. , 1998, The Journal of clinical endocrinology and metabolism.
[28] Y. Imai,et al. Decreased blood pressure variability at rest in patients with primary aldosteronism. , 1998, American journal of hypertension.
[29] W. White,et al. Circadian blood pressure variation in hypertensive patients with primary hyperaldosteronism. , 1998, Hypertension.
[30] J. Krakauer,et al. Diagnosis and Treatment of Primary Aldosteronism , 1995, Annals of Internal Medicine.
[31] F. Veglio,et al. Spectral characteristics of heart rate and blood pressure variability in primary aldosteronism. , 1995, American journal of hypertension.
[32] B. Kasiske,et al. Effects of Antihypertensive Therapy on Serum Lipids , 1995, Annals of Internal Medicine.
[33] O. Tochikubo,et al. Muscle Sympathetic Nerve Activity in Renovascular Hypertension and Primary Aldosteronism , 1991, Hypertension.
[34] H. Lithell. Effect of Antihypertensive Drugs on Insulin, Glucose, and Lipid Metabolism , 1991, Diabetes Care.
[35] M. Schalekamp,et al. Volume‐Pressure Relationships during Development of Mineralocorticoid Hypertension in Man , 1977, Circulation research.
[36] M. H. Gault,et al. Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.
[37] R. Tarazi,et al. Hemodynamic characteristics of primary aldosteronism. , 1973, The New England journal of medicine.
[38] M. Mcilroy,et al. Abnormalities of Renal Function and Circulatory Reflexes in Primary Aldosteronism , 1966, Circulation.
[39] Jeroen J. Bax,et al. 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Blood pressure.
[40] S. Malpas. Neural influences on cardiovascular variability: possibilities and pitfalls. , 2002, American journal of physiology. Heart and circulatory physiology.
[41] J D Veldhuis,et al. Increased disorderliness and amplified basal and pulsatile aldosterone secretion in patients with primary aldosteronism. , 1995, The Journal of clinical endocrinology and metabolism.
[42] R. Tarazi,et al. The sympathetic nervous system and hypertension in primary aldosteronism. , 1985, Hypertension.
[43] Cockcroft Dw,et al. Prediction of Creatinine Clearance from Serum Creatinine , 1976 .